Laser Vision Correction (LVC) is an elective, self-pay and safe surgical procedure to correct myopia and hyperopia . Since FDA approval 25 years ago, there have been a progression of technological improvements leading to better outcomes and LVC is now one of the safest surgical procedures . With a potential pool of 50 million patients, 6000 trained ophthalmic surgeons regularly treating in over 1000 centers of which 65% are physician owned . Treatments remain low from an earlier peak of 1.4 million to less than 800,000 over last 10 years . The factors preventing patients undergoing surgery have not changed and include the cost of $2000 ± $1000 per eye and fear of laser surgery on their eyes . The latter is overcome by word of mouth referrals and positive social media messaging . In addition, press misinformation and lack of optometrists participating in co-management have not helped grow LVC procedures despite the positive results of the FDA's Patient Reported Outcomes with LASIK studies known as PROWL . The surgery is quick, and patients can be``in and out"in less than two hours with a rapid recovery, minimal postoperative restrictions and within 24 hours have 20/20 vision . Volume and price drives center and physician profitability with a scheduling capacity of two to four patients' treatments per hour . Laser vision correction and especially LASIK, remains the treatment of choice for myopic and hyperopic patients wanting to remove their dependency on glasses and contact lenses.
Index: Covid-19, LASIK, contacts, excimer, glasses, optical